Timothy Sullivan - Jun 9, 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Financial Officer
Signature: /s/s David Watson, attorney-in-fact for Timothy Sullivan
Stock symbol: APLS
Transactions as of: Jun 9, 2025
Transactions value $: $1,599,675
Form type: 4
Date filed: 6/11/2025, 04:20 PM
Previous filing: Jan 30, 2025
Next filing: Sep 10, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sullivan Timothy Eugene	Chief Financial Officer	C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM	/s/s David Watson, attorney-in-fact for Timothy Sullivan	2025-06-11	0001707000

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Award	$1.6M	+82.5K		$19.39	82.5K	Jun 9, 2025	Common Stock	82.5K	$19.39	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents stock option award granted on June 9, 2025, which will vest over a two-year period. Specifically, 50% of the options will vest on each of the one-year and two-year anniversaries of the grant date, contingent upon continued service.